Six former and current employees of Bayer AG’s U.S. health care arm filed a $100 million gender discrimination lawsuit Monday, claiming the U.S. unit discriminates against its female employees in terms of pay and promotion, as well as pregnancy leave. Get the full story »
Bayer
Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
Bayer, J&J anti-clot drug shines in stroke trial
A once-daily pill being developed by Bayer AG and Johnson & Johnson was better at preventing stroke than standard treatment, with less risk of the most worrisome types of bleeding, researchers said on Monday. Get the full story »
Bayer, J&J blood pill shows mass-market promise
A new stroke prevention drug developed by Bayer and Johnson & Johnson proved a safe alternative to the standard treatment, lifting their chances of entering a $12 billion plus market, the German drug company said.
A late-stage study called Rocket-AF showed that the Xarelto pill was as good as the established warfarin pill at reducing the risk of strokes due to a form of irregular heartbeat that is common among the elderly, Bayer said on Sunday. Get the full story »
Oct. 26, 2010 at 5:15 p.m.
Comments Off
Filed under: Advertising/Marketing, Investigations, Pharmaceuticals U.S. states settle with Bayer over vitamin claims
Attorneys general in Illinois, Oregon and California said on Tuesday that Bayer AG agreed to a $3.3 million settlement over misleading claims that the drug maker’s vitamins reduced men’s risk of prostate cancer.
Under the terms of the settlement, Bayer cannot make claims that its One A Day Men’s multivitamins can prevent or cure prostate cancer or any other disease without scientific evidence, Illinois Attorney General Lisa Madigan said in a statement.
“When manufacturers like Bayer make marketing claims with insufficient scientific proof behind them, they are misleading consumers,” she said.
Get the full story »
Bayer to phase out pesticide in use since 1970
A unit of Bayer AG is phasing out production of a pesticide used on numerous U.S. crops such as cotton, peanuts and potatoes now that the U.S. Environmental Protection Agency has found that the 40-year-old product doesn’t meet food safety rules.
In a release Tuesday, the EPA said new toxicity data show that the pesticide aldicarb – marketed under the trade name Temik — no longer meets the agency’s safety standards. Get the full story »
